| Biotechnology Industry | Healthcare Sector | Sheng Jiang CEO | OTC PINK Exchange | 40423K100 CUSIP |
| CN Country | 121 Employees | 29 Jun 2005 Last Dividend | - Last Split | - IPO Date |
HH Biotechnology Holdings Company is a prominent enterprise operating within the health and green industries niche, primarily known for its cultivation and distribution of macadamia nuts. Initially established under the name Great China International Holdings, Inc., the company underwent a significant rebranding in August 2016 to better reflect its commitment to biotechnology and sustainable practices, adopting the name HH Biotechnology Holdings Company. Since its incorporation in 1987, it has anchored its headquarters in Shenyang, located in the People's Republic of China, indicating its strong roots in the region and its strategic positioning in the Asian market. The company's involvement in the health and green industries underscores a growing trend towards sustainability and health consciousness among consumers and industries alike.